Literature DB >> 3221360

Clinical signs of tumors affecting the rostral cerebrum in 43 dogs.

E S Foster1, J M Carrillo, A K Patnaik.   

Abstract

The clinical and pathologic features of 43 dogs with neoplasia of the rostral cerebrum were reviewed. Primary brain tumors included meningioma, astrocytoma, neuroblastoma, oligodendroglioma, and ependymoma. Other tumors that secondarily affected these areas included solitary hemangiosarcoma, nasal neuroendocrine carcinoma, nasal cell adenocarcinoma, nasal squamous cell carcinoma, and nasal neurofibrosarcoma. Older dogs were usually affected (mean, 10 years), and meningioma was the most frequent tumor type. Thirty-one dogs (72% of total) had a late-onset (greater than 5 years of age) of either generalized seizures or behavior abnormalities, or both, with an initially normal neurologic examination. In these 31 dogs, a mean time of 78 days (range, 2 to 400 days) elapsed from the onset of seizures or behavior change to the detection of a persistently abnormal neurologic examination. In all 43 dogs, the time from the detection of neurologic deficits to death or euthanasia and necropsy ranged from 1 to 63 days (mean, 13 days). On the basis of this review, it appears that dogs with late-onset seizures or behavior change, or both, should be suspected of having tumors involving the rostral cerebrum, despite the absence of persistent neurologic deficits commonly associated with cerebral tumors. Further, the onset of abnormalities in the neurologic examination and the time of death seem to occur within predictable time periods.

Entities:  

Mesh:

Year:  1988        PMID: 3221360     DOI: 10.1111/j.1939-1676.1988.tb02796.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  21 in total

1.  Adenoviral-mediated gene transfer into the canine brain in vivo.

Authors:  Marianela Candolfi; Kurt M Kroeger; G Elizabeth Pluhar; Josee Bergeron; Mariana Puntel; James F Curtin; Elizabeth A McNiel; Andrew B Freese; John R Ohlfest; Peter Moore; Pedro R Lowenstein; Maria G Castro
Journal:  Neurosurgery       Date:  2007-01       Impact factor: 4.654

2.  Surgical treatment and radiation therapy of frontal lobe meningiomas in 7 dogs.

Authors:  Ane Uriarte; Pierre Moissonnier; Jean-Laurent Thibaud; Edouard Reyes-Gomez; Patrick Devauchelle; Stéphane Blot
Journal:  Can Vet J       Date:  2011-07       Impact factor: 1.008

Review 3.  Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.

Authors:  Michael R Olin; G Elizabeth Pluhar; Brian M Andersen; Rob Shaver; Nate N Waldron; Christopher L Moertel
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

4.  Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy.

Authors:  G Elizabeth Pluhar; Patrick T Grogan; Charlie Seiler; Michelle Goulart; Karen S Santacruz; Cathy Carlson; Wei Chen; Mike R Olin; Pedro R Lowenstein; Maria G Castro; Stephen J Haines; John R Ohlfest
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

5.  Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.

Authors:  Marianela Candolfi; James F Curtin; W Stephen Nichols; Akm G Muhammad; Gwendalyn D King; G Elizabeth Pluhar; Elizabeth A McNiel; John R Ohlfest; Andrew B Freese; Peter F Moore; Jonathan Lerner; Pedro R Lowenstein; Maria G Castro
Journal:  J Neurooncol       Date:  2007-09-15       Impact factor: 4.130

6.  Epidemiology of seizures in children with brain tumors. The Childhood Brain Tumor Consortium.

Authors:  F H Gilles; E Sobel; A Leviton; E T Hedley-Whyte; C J Tavare; L S Adelman; R A Sobel
Journal:  J Neurooncol       Date:  1992-01       Impact factor: 4.130

7.  Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.

Authors:  Weidong Xiong; Marianela Candolfi; Chunyan Liu; A K M Ghulam Muhammad; Kader Yagiz; Mariana Puntel; Peter F Moore; Julie Avalos; John D Young; Dorothy Khan; Randy Donelson; G Elizabeth Pluhar; John R Ohlfest; Kolja Wawrowsky; Pedro R Lowenstein; Maria G Castro
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

Review 8.  Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.

Authors:  Marianela Candolfi; Kurt M Kroeger; A K M G Muhammad; Kader Yagiz; Catherine Farrokhi; Robert N Pechnick; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

9.  A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion.

Authors:  Laura M Shelton; Purna Mukherjee; Leanne C Huysentruyt; Ivan Urits; Joshua A Rosenberg; Thomas N Seyfried
Journal:  J Neurooncol       Date:  2010-01-13       Impact factor: 4.130

10.  Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.

Authors:  Marianela Candolfi; G Elizabeth Pluhar; Kurt Kroeger; Mariana Puntel; James Curtin; Carlos Barcia; A K M Ghulam Muhammad; Weidong Xiong; Chunyan Liu; Sonali Mondkar; William Kuoy; Terry Kang; Elizabeth A McNeil; Andrew B Freese; John R Ohlfest; Peter Moore; Donna Palmer; Phillip Ng; John D Young; Pedro R Lowenstein; Maria G Castro
Journal:  Neuro Oncol       Date:  2007-05-23       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.